Aberdeen Group
INZY

Aberdeen Group’s Inozyme Pharma INZY Stock Holding History

Aberdeen Group’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-326,758
Closed -$297K – 968
2025
Q1 		$297K Buy
326,758
+156,236
+92% +$142K ﹤0.01% 905
2024
Q4 		$472K Buy
+170,522
New +$472K ﹤0.01% 875